Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020381

Expand all

NIASPAN (NIACIN)
500MG Marketing Status: Prescription

Active Ingredient: NIACIN
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 500MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020381
Product Number: 002
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

NIASPAN (NIACIN)
750MG Marketing Status: Prescription

Active Ingredient: NIACIN
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 750MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020381
Product Number: 003
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

NIASPAN (NIACIN)
1GM Marketing Status: Prescription

Active Ingredient: NIACIN
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 1GM
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020381
Product Number: 004
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Prescription
Patent and Exclusivity Information

NIASPAN (NIACIN)
375MG Marketing Status: Discontinued

Active Ingredient: NIACIN
Proprietary Name: NIASPAN
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 375MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020381
Product Number: 001
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

NIASPAN TITRATION STARTER PACK (NIACIN)
375MG;500MG;750MG Marketing Status: Discontinued

Active Ingredient: NIACIN
Proprietary Name: NIASPAN TITRATION STARTER PACK
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 375MG;500MG;750MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020381
Product Number: 005
Approval Date: Jul 28, 1997
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English